Your browser doesn't support javascript.
loading
Levels and determinants of urinary cadmium in general population in Spain: Metal-MCC-Spain study.
Blanco Muñoz, Julia; Lope, Virginia; Fernández de Larrea-Baz, Nerea; Gómez-Ariza, José Luis; Dierssen-Sotos, Trinidad; Fernández-Tardón, Guillermo; Aragonés, Nuria; Amiano, Pilar; Gómez-Acebo, Inés; Tardón, Adonina; Grau-Pérez, María; García-Barrera, Tamara; Kogevinas, Manolis; Pollán, Marina; Pérez-Gómez, Beatriz.
Afiliación
  • Blanco Muñoz J; Department of Environmental Health. Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico.
  • Lope V; Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 2
  • Fernández de Larrea-Baz N; Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 2
  • Gómez-Ariza JL; Department of Chemistry, Faculty of Experimental Sciences, Campus El Carmen, University of Huelva. Research Center for Natural Resources, Health and the Environment, Campus El Carmen, University of Huelva, Av. del Tres de Marzo, 3, 21007, Huelva, Spain.
  • Dierssen-Sotos T; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Universidad de Cantabria - IDIVAL, 39011, Santander, Spain.
  • Fernández-Tardón G; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Institute of Health Research of the Principality of Asturias (ISPA)/University of Oviedo, 03301, Oviedo, Spain.
  • Aragonés N; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain. C/San Martín de Porres, 6, 28035, Madrid, Spai
  • Amiano P; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Sub-Directorate for Public Health and Addictions of Gipuzkoa, Ministry of Health of the Basque Government, 20013, San Sebastian, Spain; Epi
  • Gómez-Acebo I; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Universidad de Cantabria - IDIVAL, 39011, Santander, Spain.
  • Tardón A; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Institute of Health Research of the Principality of Asturias (ISPA)/University of Oviedo, 03301, Oviedo, Spain.
  • Grau-Pérez M; Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid/ IdiPAZ, 28049, Madrid, Spain; Cardiometabolic and Renal Risk Unit, Biomedical Research Institute INCLIVA, Valencia, Spain.
  • García-Barrera T; Department of Chemistry, Faculty of Experimental Sciences, Campus El Carmen, University of Huelva. Research Center for Natural Resources, Health and the Environment, Campus El Carmen, University of Huelva, Av. del Tres de Marzo, 3, 21007, Huelva, Spain.
  • Kogevinas M; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Instituto de Salud Global de Barcelona (ISGlobal), 08003, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), 08003, Barc
  • Pollán M; Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 2
  • Pérez-Gómez B; Department of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Av/Monforte de Lemos, 5, 28029, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III. Av/Monforte de Lemos, 5, 2
Environ Res ; 210: 112959, 2022 07.
Article en En | MEDLINE | ID: mdl-35189102
ABSTRACT

BACKGROUND:

Cadmium is a ubiquitous and persistent metal, associated with different harmful health effects and with increased morbidity and mortality. Understanding the main sources of exposure is essential to identify at risk populations and to design public health interventions.

OBJECTIVE:

To evaluate cadmium exposure in a random-sample of general adult population from three regions of Spain, assessed by the urinary cadmium (U-Cd) concentration, and to identify its potential determinants and sex-specific differences, including sociodemographic, lifestyle and dietary factors. MATERIALS AND

METHODS:

We measured U-Cd (µg/g creatinine) in single urine spot samples from 1282 controls enrolled in the multicase-control study in common tumors in Spain (MCC-Spain) with inductively coupling plasma-mass spectrometry equipped with an octopole reaction systems (ICP-ORS-MS). The association between sociodemographic, lifestyle, and dietary characteristics and U-Cd concentrations was evaluated using geometric mean ratios (GMR) estimated by multiple log-linear regression models.

RESULTS:

Overall, geometric mean U-Cd concentration was 0.40 (95%CI 0.38, 0.41) µg/g creatinine. Levels were higher in women than in men (GMR] 1.19; 95%CI 1.07, 1.32), and increased with age in males (ptrend< 0.001). Cigarette smoking was clearly associated to U-Cd levels (GMRformer vs non-smokers 1.16; 95%CI 1.05, 1.29; GMRcurrent vs non-smokers 1.42; 95%CI 1.26, 1.60); the relationship with secondhand tobacco exposure in non-smokers, was restricted to women (pinteraction = 0.02). Sampling season and region also seemed to influence U-Cd concentrations, with lower levels in summer (GMRsummer vs average 0.79; 95%CI 0.71, 0.88), and higher levels in North-Spain Asturias (GMRAsturias vs average 1.13; 95%CI 1.04, 1.23). Regarding diet, higher U-Cd concentration was associated with eggs consumption only in men (pinteraction = 0.04), just as rice intake was associated in women (pinteraction = 0.03).

CONCLUSION:

These results confirmed that tobacco exposure is the main modifiable predictor of U-Cd concentrations, and remark that the role of dietary/sociodemographic factors on U-Cd levels may differ by sex.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cadmio / Exposición a Riesgos Ambientales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Environ Res Año: 2022 Tipo del documento: Article País de afiliación: México

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cadmio / Exposición a Riesgos Ambientales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Environ Res Año: 2022 Tipo del documento: Article País de afiliación: México